antibodies

Latest

antibodies

·May 26, 2020

First results from human COVID-19 immunology study reveal universally effective antibodies

While the amount of antibodies generated varies widely in patients who have recovered from coronavirus, most people generate at least some antibodies which are intrinsically capable of neutralizing the SARS-CoV-2 virus. Read More

Featured Neuroscience Neuroscience Videos

·May 18, 2020

Antibody neutralizes SARS and COVID-19 coronaviruses

S309, a neutralizing antibody first identified in blood samples from a patient who recovered from SARS in 2003, shows promise for the treatment of COVID-19. Read More

Featured Genetics Neuroscience neurotech

·May 17, 2020

Designing vaccines from artificial proteins

Using computational methods, researchers created artificial proteins that triggered immune responses and produced infection specific antibodies. The findings indicate it will be possible to design vaccines that contain artificial antibodies, expediting the process of vaccine development. Read More

Featured Neuroscience Open Neuroscience Articles

·May 5, 2020

Recently recovered COVID-19 patients produce varying virus-specific antibodies

Recovered coronavirus patients show a wide range of immune responses following the infection, with about half from a current study showing sustained antibodies two weeks later. Results indicate which parts of the virus are most effective at triggering the immune responses. Read More

Featured Neuroscience Open Neuroscience Articles

·May 5, 2020

Fully human antibody that blocks infection from coronavirus SARS-CoV-2 in cells identified

Researchers have identified a fully human monoclonal antibody that prevents SARS-CoV-2, the virus that causes COVID-19, from infecting cultured cells. The antibody binds to a domain that is conserved in SARS-CoV-2, neutralizing the virus. The findings are an initial step towards developing a fully human antibody to prevent or treat coronavirus. Read More

Featured Genetics Neuroscience

·April 22, 2020

Using ‘elite’ antibodies from COVID-19 survivors to develop potent therapies

Researchers are sifting through millions of antibodies produced by those who have recovered from COVID-19 to find which ones neutralize the virus. The team has already identified several antibodies that block coronavirus from interacting with its receptors. Read More

Featured Genetics Neuroscience Psychology

·April 21, 2020

Antibodies could provide new treatment for OCD

People with OCD have six times higher Immuno-moodulin (Imood) expression that those without the disorder. Blocking Imood with the aid of an antibody reduced OCD-like behaviors in mouse models within a couple of days following treatment. Read More

Featured Genetics Neuroscience

·April 16, 2020

Proteins may halt the severe cytokine storms seen in COVID-19 patients

Researchers have designed antibody-like receptor proteins that can bind to cytokines, possibly reducing the effects of the COVID-19 associated cytokine storm. Read More

Featured Neuroscience Open Neuroscience Articles

·April 16, 2020

Development of antibody research may help prevent sepsis induced by COVID-19

Researchers have developed a novel antibody strategy to prevent the association between a harmless protein and a disease mediator that could lead to sepsis, and ultimately death. The findings could help to prevent sepsis induced by COVID-19 infections. Read More

Featured Neuroscience

·April 4, 2020

Clues to COVID-19 coronavirus’s vulnerability emerge from an antibody against SARS

Structural mapping of both SARS and SARS-CoV-2, the virus that causes COVID-19, reveals an almost identical site on both coronaviruses to which the CR3022 antibody binds. This suggests a functionally important and vulnerable site for this family of coronaviruses. Read More

Featured Neurology Neuroscience

·March 24, 2020

Antibodies in the brain trigger epilepsy

Anti-Drebrin auto-antibodies may be responsible for limbic encephalitis. Read More

Featured Neuroscience Open Neuroscience Articles

·March 15, 2020

Antibodies from COVID-19 survivors could be used to treat patients and protect those at risk

Johns Hopkins University researchers propose using antibodies from the plasma or serum of those who have recovered from COVID-19 to help boost the immunity of newly infected patients and for those at risk of contracting the disease. Researchers say the antibodies may bind to and neutralize SARS-CoV-2. The technique has been proven successful in prior outbreaks, including the SARS epidemic and the 1918 flu pandemic. Read More

1 2